CellChorus expands advisory board

Advisors include industry experts across artificial intelligence, life science commercialization, oncology, and infectious diseases

PRESS RELEASE

HOUSTON, Texas — October 18, 2023 — CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how cells perform and interact over time, announced the expansion of its scientific and commercial advisory board. The board will advise the company on scaling the TIMING™ platform across a variety of therapeutic areas to improve the development and manufacture of immune cell-based therapies.

Members of the scientific and commercial advisory board include:

  • Julien Bradley is the CEO of Axion Biosciences. He is the former CEO of RedShiftBio and the former VP of Marketing, Corporate Development & Strategy at Quanterix. He has also held senior management positions at Phosphorus, OvaScience, and Thermo Fisher Scientific.

  • Mimi Healy, PhD is the CEO of Stimulus Bio, a product development and commercialization firm. She is the former Chief Product Officer of Berkeley Lights, the former Head of NGS Systems at Agilent Technologies, and the former President and CEO of Lasergen prior to its acquisition by Agilent Technologies.

  • Gene Karshenboym is the Head of Geo Auto Partner Engineering at Google. He is the former CEO of Phiar, an ultra-lightweight AI spatial analysis company for augmented reality (AR) navigation that was acquired by Google. Gene is the former Global Manager of Android Automotive Hardware Platforms at Google.

  • Krishna Komanduri, MD, is the Julius R. Krevans Distinguished Professor in Internal Medicine and Clinical Director of the Living Therapeutics Initiative at UCSF. He is the Chief of the Division of Hematology and Oncology and Physician-in-Chief at the Helen Diller Family Comprehensive Cancer Center. Dr. Komanduri is a past President and honorary Fellow of the American Society for Transplantation and Cellular Therapy. He is an elected member of the Henry Kunkel Society and the American Society of Clinical Investigation.

  • Dimitrios Kontoyiannis, MD, PhD, is the Robert C. Hickey Chair in Clinical Care and Deputy Head in the Division of Internal Medicine at the MD Anderson Cancer Center. He is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the European Confederation for Medical Mycology, the American Academy of Microbiology, and the American Association for the Advancement of Science (AAAS).

  • Badri Roysam, DSc, is the Hugh Roy and Lillie Cranz Cullen University Professor, and Chairman of the Electrical and Computer Engineering Department at the University of Houston, and a Professor of Computer Science. From 1989 to 2010, he was a Professor at Rensselaer Polytechnic Institute in Troy, New York, USA, where he directed the Rensselaer unit of the NSF Engineering Research (ERC) Center for Subsurface Sensing and Imaging Systems (CenSSIS ERC), and co-directed the Rensselaer Center for Open Source Software (RCOS). He is a fellow of the IEEE and the AIMBE.

“CellChorus is advancing the next frontier of single-cell analysis to provide a comprehensive understanding of how immune cells interact and perform,” said Daniel Meyer, CEO of CellChorus. “We are thrilled to have such a high-quality group of advisors as we scale the TIMING platform for research, development and manufacturing in immunotherapy.”

About CellChorus

CellChorus is the leader in applying artificial intelligence (AI) to visually evaluate how thousands of individual immune cells, such as T cells and NK cells, perform over time. The company applies Time lapse Imaging Microscopy in Nanowell Grids™ (TIMING™) with neural network-based AI to identify cells and evaluate their activity, including how they move, activate, kill and survive. The patent-protected CellChorus platform can link TIMING data and insights with information from other analysis modalities such as single-cell RNA sequencing and flow cytometry to provide a comprehensive understanding of cellular function, state and phenotype for the life sciences industry. Please visit cellchorus.com for more information.

Company Contact:
Daniel Meyer
Chief Executive Officer
CellChorus Inc.
TIMING@cellchorus.com

SOURCE CellChorus Inc.